Zura Bio Ltd. (ZURA)
1.405
+0.16
(+13.31%)
USD |
NASDAQ |
Nov 10, 16:00
1.39
-0.02
(-1.07%)
After-Hours: 20:00
Zura Bio EPS Diluted (Quarterly) : -0.2022 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2022 |
| June 30, 2026 | -0.2074 |
| March 31, 2026 | -0.2159 |
| December 31, 2025 | -0.6227 |
| September 30, 2025 | -0.2119 |
| June 30, 2025 | -0.1696 |
| March 31, 2025 | -0.1876 |
| December 31, 2024 | -0.1386 |
| September 30, 2024 | -0.2627 |
| June 30, 2024 | -0.169 |
| March 31, 2024 | -0.0156 |
| December 31, 2023 | -0.144 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1764 |
| June 30, 2023 | -1.309 |
| March 31, 2023 | -2.758 |
| December 31, 2022 | 0.7765 |
| September 30, 2022 | -2.874 |
| June 30, 2022 | -9.536 |
| March 31, 2022 | -72398.15 |
| December 31, 2021 | 0.0474 |
| September 30, 2021 | 0.3355 |
| June 30, 2021 | -0.0011 |
| March 31, 2021 | -0.0019 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2611 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.3451 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.82M |
| Total Expenses (Quarterly) | 25.82M |
| Enterprise Value | -68.23M |
| Earnings Yield | -88.84% |
| Normalized Earnings Yield | -88.84 |